Early Stage Detection of Cervical Cancer Improves Survival for Women Under 65

Narrative-hero_Surveillance_1060x597-4

Julianne Cooley, a senior statistician with the California Cancer Reporting and Epidemiologic Surveillance Program, summarizes her study published in the American Association for Cancer Research Journal.

Background

Through adequate screening and follow-up, cervical cancer can be prevented or detected at early-stage (stage I), which is related to excellent survival. Current guidelines recommend discontinuing screening for women ≥65 years with a history of normal Pap and/or HPV tests, potentially leaving this age group vulnerable. This study examined late-stage disease in a population-based cohort.

Methods

Using California Cancer Registry data, we identified 12,442 patients ages ≥21 years with a first primary cervical cancer diagnosis during 2009–2018. Proportions of late-stage disease (stages II–IV) and early- and late-stage 5-year relative survival are presented by the age group. Among patients ages ≥65 years, multivariable logistic regression estimated associations of sociodemographic and clinical characteristics with late-stage cervical cancer.

Results

Nearly one fifth of patients (n = 2,171, 17.4%) were ≥65 years. More women ages ≥65 years (71%) presented with late-stage disease than younger women (48% in patients ages <65). Late-stage 5-year relative survival was lower for women ≥65 years (23.2%–36.8%) compared with patients <65 (41.5%–51.5%). Characteristics associated with late-stage cervical cancer in women ≥65 years included older age [odds ratio (OR), 1.02; 95% confidence interval (CI), 1.01–1.04; each year], non-adenocarcinoma histologic subtypes, and comorbidities (OR, 1.59; 95% CI, 1.21–2.08).

Conclusions

There remains a significant burden of advanced cervical cancer in women ≥65.

Impact

Efforts should be made to better understand how the current screening paradigm is failing women of 65 years and older. Future work should focus on determining past screening history, lapses in follow-up care, and non-invasive testing approaches.

This data can help us promote efforts to improve screening, testing, and overall care for women under 65.

What to Read Next

Racial Disparities in HPV-Related Oropharyngeal Cancer Outcomes

Interventions to increase HPV vaccine uptake, early detection, and treatment of oropharyngeal cancer in males are needed to decrease disparities…

Determining Cancer Mortality in Latino Populations by Birthplace and Generation

In a recent editorial, registry data hold unique opportunities for linkages that will accurately characterize racial-ethnic groups in the U.S….

One-Third of Women With Cervical Cancer in California Present Symptomatically

Cervical cancer can mostly be prevented or detected very early before symptoms develop, yet it persists. After large declines in…